Decision to suspend implants may spark excessive breast cancer concern Concerned women with textured breast implants linked to a rare cancer are likely to seek advice from their GP, an expert has told newsGP.
‘Unexplained pharmaceuticals’ found in complementary and alternative medicines Nearly half of the 135 complementary and alternative medicines tested by researchers had contaminants, including animal DNA and potential allergens.
Opioid pack changes ‘long overdue’, but more reform needed From 2020, opioid packages will be smaller and feature improved labels with clearer warnings and consumer information.
Opioid marketing scrutinised by TGA, questioned by RACGP The Therapeutic Goods Administration has confirmed it is examining opioid marketing material aimed at GPs.
What should GPs know about bioidentical hormone therapy? Two experts answer common questions on compounding bioidentical hormone therapy for menopause.
Food labelling: When is a medicine not a medicine? Concerns have been raised over alleged double standards regarding the regulation of food products promoted as having ‘special medical purposes’.
TGA criticised over lack of safety warnings Questions have been raised over the way Australia’s therapeutic regulator is informing doctors and patients about potentially dangerous drugs.
Codeine supply in Australia has almost halved The massive decrease has been attributed to the 2018 decision to up-schedule codeine to a Schedule 4 prescription-only medicine.
Why down-scheduling medicines is fraught with danger Assoc Prof Mark Morgan questions whether a push to make more prescription-only medicines available over the counter is best for patients.
It may be ‘natural’, but is it healthy? RACGP supports the TGA’s move to ensure advertising claims of ‘natural’ ingredients in therapeutic goods are not misleading.